Multi-Chem Limited (AWZ) AI Stock Analysis

• Market Cap: S$308.13M
• Dividend Yield: 7.53%
• Average Volume (3M): 11.70K
• Price to Earnings (P/E): 6.3
• Beta (1Y): 0.54
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: SG
• Employees: 582
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): 0.14
• Shares Outstanding: 90,095,290
• 10 Day Avg. Volume: 12,740
• 30 Day Avg. Volume: 11,696
• PEG Ratio: -3.48
• Price to Book (P/B): 2.01
• Price to Sales (P/S): 0.47
• P/FCF Ratio: 7.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 82 Outperform
• Price Target: S$4.00 ▲(16.28% Upside)
• Action: Reiterated Date: 02/26/26
• Date: Action: Reiterated 02/26/26

The score is supported primarily by strong financial resilience (low leverage and solid cash generation). Technicals also indicate a steady uptrend with positive momentum, while valuation is attractive due to a moderate P/E and high dividend yield. The key risk tempering the score is the recent softening in growth and earnings versus the 2023 peak.

Positive Factors

Conservative Balance Sheet

Very low leverage provides durable financial flexibility: it reduces refinancing risk, supports capacity for capital allocation (dividends, buybacks, M&A or capex), and increases resilience in economic downturns, a structural strength for the next 2–6 months.

Strong Free Cash Flow Conversion

Near-1x FCF-to-net-income conversion signals high earnings quality and persistent cash generation ability. This durable cash conversion underpins reinvestment, shareholder distributions, and balance-sheet repair, cushioning the business through uneven earnings cycles.

Revenue Resilience

A broadly stable top line implies a resilient service mix and steady client demand. Even with uneven year-to-year growth, stable revenues provide a reliable base for margins and cash flow planning and reduce downside risk to operating capacity over the medium term.

Negative Factors

Softening Earnings Momentum

A peak followed by multi-year earnings softening indicates structural pressures on profitability or demand that could persist. Weaker earnings limit reinvestment and shareholder returns and may signal deteriorating operating leverage or competitive headwinds over the coming months.

Modest Profit Margins

Relatively low gross and net margins reduce the firm's ability to absorb cost inflation or fund strategic initiatives from operating profits. Modest margin structure constrains long-term return on capital and leaves less room for margin expansion during growth recoveries.

Volatile Free Cash Flow Growth

Significant FCF growth swings complicate budgeting and capital-allocation planning. This volatility—likely from working-capital or timing effects—weakens predictability of dividends, buybacks or reinvestment and raises execution risk for strategic initiatives.

Multi-Chem Limited Business Overview & Revenue Model

Company Description

Multi-Chem Limited, an investment holding company, distributes information technology products in Singapore, Greater China, Australia, India, and internationally. It operates through two segments, Printed Circuit Board (PCB) Business and IT Business. The company distributes hardware and software relating to internet and network products, as well as related installation, technical, and maintenance services. It also offers PCB related services to PCB fabricators. In addition, the company distributes a range of specialty chemicals; and PCB-related materials and equipment, including entry and back-up materials for drilling, non-woven brushes to ensure clean copper surface with suitable roughness, tacky rollers, tack cloth/wipes, cleaning machine to remove foreign particles on PCBs, automatic drills regrinding machines, and x-ray inspection machines. Further, it leases machines; offers software consultancy and implementation services; and provides IT training courses. Multi-Chem Limited was incorporated in 1985 and is headquartered in Singapore.

How the Company Makes Money

Multi-Chem Limited generates revenue through the sale of its specialty chemical products and services. The primary revenue streams include the direct sale of chemical formulations to industrial clients, recurring revenue from long-term contracts in the oil and gas sector, and consulting services that help optimize chemical usage in manufacturing processes. Additionally, the company benefits from strategic partnerships with key industry players, enabling it to expand its market reach and enhance product offerings. Factors such as strong customer relationships, a focus on R&D for innovative product development, and a growing demand for eco-friendly and efficient chemical solutions also contribute to its earnings.

Multi-Chem Limited Financial Statement Overview

Summary

Strong overall financial quality driven by a conservatively financed balance sheet (very low leverage) and consistently strong free-cash-flow conversion. The main constraint is softer revenue and earnings momentum after a 2023 peak, with modest margins and uneven growth in 2024–2025.

Income Statement

Revenue has been broadly stable over the last few years, but growth has been uneven—strong in 2021 and 2023, followed by modest declines in 2024 and 2025. Profitability is steady but not high: gross margin has held around the mid-teens historically, while net margin has generally sat around ~3%–5%. Earnings peaked in 2023 and then softened in 2024–2025, suggesting some pressure on operating leverage and/or cost discipline despite a resilient top line.

Balance Sheet

The balance sheet is conservatively positioned with very low debt relative to equity across the period, indicating minimal leverage risk. Equity has remained substantial and generally stable, supporting financial flexibility. The main weakness is that returns on equity, while healthy in 2023–2024, have trended lower more recently alongside softer earnings, which could limit balance-sheet-driven value creation if the profit slowdown persists.

Cash Flow

Cash generation is a clear strength: free cash flow has been consistently strong relative to net income (near 1x in 2021–2024), indicating good earnings quality and conversion. Operating cash flow and free cash flow improved meaningfully versus 2022, and 2025 still shows robust absolute cash flow despite a decline in free cash flow growth. The key weakness is volatility in year-to-year free cash flow growth (including sharp swings), which can complicate forecasting and suggests sensitivity to working capital or timing effects.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	653.92M	658.42M	683.68M	616.98M	603.64M
Gross Profit	88.81M	94.79M	97.48M	87.01M	85.51M
EBITDA	29.64M	39.25M	42.64M	24.22M	32.60M
Net Income	26.44M	27.12M	30.82M	20.00M	24.96M
Balance Sheet
Total Assets	390.34M	402.43M	381.61M	329.30M	298.44M
Cash, Cash Equivalents and Short-Term Investments	99.49M	83.82M	73.54M	69.54M	74.41M
Total Debt	1.44M	2.19M	2.69M	3.42M	5.01M
Total Liabilities	238.09M	248.22M	237.40M	192.21M	168.25M
Stockholders Equity	152.25M	155.25M	145.25M	137.10M	130.20M
Cash Flow
Free Cash Flow	43.09M	36.12M	24.84M	10.97M	25.78M
Operating Cash Flow	43.69M	36.64M	25.19M	12.12M	26.95M
Investing Cash Flow	-521.00K	128.00K	-304.00K	-939.00K	-896.00K
Financing Cash Flow	-23.58M	-27.29M	-20.35M	-14.50M	-20.15M

Multi-Chem Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.44
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:AWZ, the sentiment is Negative. The current price of 3.44 is below the 20-day moving average (MA) of 3.45, above the 50-day MA of 3.42, and above the 200-day MA of 3.32, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 47.10 is Neutral, neither overbought nor oversold. The STOCH value of 27.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:AWZ.

Multi-Chem Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AWZ	82 Outperform	S$308.13M	6.26	―	7.53%	―	―
5DD	75 Outperform	S$266.94M	15.23	26.24%	3.73%	12.70%	48.43%
E28	71 Outperform	S$851.26M	15.07	9.11%	1.88%	11.57%	0.89%
8AZ	71 Outperform	S$605.86M	12.58	16.42%	17.05%	-50.75%	-61.46%
AWX	65 Neutral	S$1.05B	31.84	3.48%	―	4.60%	―
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%